Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement

Background Current guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. However, there is no direct evidence from randomized controlled tr...

Description complète

Détails bibliographiques

Auteurs principaux:	Ran Liu, Yang Li, Lihua Zhang, Zhinan Lu, Zhaolin Fu, Thomas Modine, Hasan Jilahawi, Stuart Pocock, Yongjian Wu, Guangyuan Song
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2025-04-01
Collection:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Sujets:	antiplatelet therapy aortic stenosis transcatheter aortic valve replacement treatment withdrawal
Accès en ligne:	https://www.ahajournals.org/doi/10.1161/JAHA.124.039350
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!